One World Biotech
OneWorld Biotech is a privately held Pennsylvania-based CRO founded in 2007 that provides custom recombinant protein production (ProteoWay™), molecular cloning and nucleic acid services (NucleoWay™), and assay development to biotech and pharmaceutical R&D clients through project-based engagements from a single Warminster lab.
- Company typePrivate
- Founded2007
- HeadquartersWarminster, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What One World Biotech does
OneWorld Biotech Inc. is a privately held Contract Research Organization (CRO) founded in 2007 and headquartered in a 3,500 square-foot laboratory facility in Warminster, Pennsylvania, approximately 30 miles north of Philadelphia. The company provides project-specific custom services to biotech and pharmaceutical R&D clients across three branded platforms: ProteoWay™ for recombinant protein expression and purification optimization, NucleoWay™ for molecular cloning and nucleic acid services, and a custom assay development offering spanning immunoassays (ELISA, lateral flow, multiplex bead-based), cell-based assays, enzyme assays, and DNA/RNA-based assays. The company's stated specialization is in technically difficult protein production, complex custom assay design, and cost-effective molecular cloning — projects that internal R&D teams often outsource to specialist providers.
The underlying technical capability combines protein engineering, multiple expression host systems (mammalian, insect, microbial, and cell-free), single-use bioreactor scale-up to 20L+ via Wave™ and Airlift systems, HEPA-filtered nucleic acid work areas, and a proprietary "Quality by Design" methodology applied across assay development and RNA synthesis. The team is small but carries more than 100 combined years of bench experience in molecular biology, protein engineering, expression and purification, cell culture, and assay development. Two registered trademarks (ProteoWay™ and NucleoWay™) anchor the brand identity, though no patents or formal IP filings are disclosed. The company explicitly emphasizes integration into clients' R&D workflows and collaborative problem-solving rather than transactional service delivery.
The business model is professional services on a custom project basis: revenue is generated through individually scoped protein production, molecular cloning, and assay development projects quoted per engagement, with a free no-obligation initial consultation offered as the top-of-funnel entry point. Go-to-market is direct sales and enterprise field sales targeting biotech and pharma clients, with the company website as the primary marketing channel and minimal paid marketing or partnerships disclosed. The company is founder-owned, has no disclosed venture capital or private equity backing, and operates without disclosed framework agreements or long-term contracts, making revenue dependent on project-by-project wins within the Mid-Atlantic and Northeast US pharma/biotech corridor and select international partners.
One World Biotech firmographics
Firmographics- Name
- One World Biotech
- Legal name
- OneWorld Biotech Inc
- Website
- https://oneworldbiotech.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- OneWorld Biotech is a privately held Pennsylvania-based CRO founded in 2007 that provides custom recombinant protein production (ProteoWay™), molecular cloning and nucleic acid services (NucleoWay™), and assay development to biotech and pharmaceutical R&D clients through project-based engagements from a single Warminster lab.
- Ownership category
- akta.pro rank
One World Biotech industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
- akta.pro secondary industry
- Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)
Keywords
Where One World Biotech is headquartered
LocationHeadquarters
- HQ city
- Warminster
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
One World Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Custom CRO Services: Project-based professional services for protein production, assay development, and molecular cloning. Revenue generated through customized project engagements tailored to client specifications, typically as one-time or milestone-based project contracts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Free initial consultation |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
One World Biotech product offering
Product offeringCore offering
OneWorld Biotech is a Contract Research Organization (CRO) that delivers fully custom, project-based protein expression and purification, molecular cloning and RNA synthesis, and assay development services to biotech and pharmaceutical clients. The company specializes in difficult-to-express proteins, complex custom assay design, and cost-effective cloning projects using proprietary ProteoWay™ and NucleoWay™ platforms across microbial, insect, mammalian, and cell-free expression systems. All work is executed in-house at its 3,500 sq ft HEPA-filtered laboratory in Warminster, Pennsylvania.
Product overview
OneWorld Biotech is a Contract Research Organization (CRO) offering specialized biotech R&D services through three main branded platforms: ProteoWay™ for protein production and expression optimization, NucleoWay™ for molecular cloning and RNA services, and custom assay development services. The company provides project-specific, truly custom services specializing in difficult protein production, complex assay development, and cost-effective molecular cloning projects. Services span from vector design through protein characterization, with expertise in microbial, insect, and mammalian expression systems.
Differentiator
Problem solved
Functional benefit
Brands
- ProteoWay: Protein Production Optimization platform ensuring high quality biologically active protein through optimized vector design, host selection, culture conditions and purification.
- NucleoWay
Products and services
- ProteoWay™ Protein Production A custom protein expression and purification service using the proprietary ProteoWay™ platform that systematically optimizes each stage of recombinant protein production — from vector design and host selection through culture conditions and purification to protein characterization — to deliver high-quality biologically active protein for biotech and pharma R&D clients.
- NucleoWay™ Molecular Cloning A custom molecular cloning and RNA services offering under the NucleoWay™ brand that delivers custom gene cloning, vector construction, RNA and mRNA synthesis, plasmid DNA and RNA purification, and other DNA/RNA analysis projects for biotech and pharma clients.
- Assay Development Services A custom assay design and manufacture service applying a Quality by Design approach that uses custom-designed reagents and sourced assay components to create validated assay systems, including immunoassays (ELISA, Lateral Flow, multiplex bead-based), cell-based assays, enzyme assays, and DNA/RNA-based assays for biotech and pharma clients.
Companies that use One World Biotech
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
One World Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
One World Biotech partnerships and signals
Strategic signalScale indicators6 records
Recent moves5 records
Expansion highlights4 records
One World Biotech competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Eurofins is a large international CRO offering protein production, molecular biology, and bioanalytical services across many hosts, overlapping with OneWorld's core services but as part of a much broader testing and life sciences portfolio.
- Bio-Techne: Bio-Techne provides proteins, antibodies, and assay kits and also offers custom protein production and assay development services — comparable to OneWorld's ProteoWay™ and assay development offerings, but at significantly larger scale.
- Thermo Fisher Scientific: Thermo Fisher's Life Sciences Solutions and PPD CRO segments provide protein expression, custom cloning, and assay development services as part of a massive life sciences tools and services portfolio — broad incumbent competing with OneWorld in custom services.
- WuXi AppTec: WuXi AppTec operates a global CRO/CDMO network offering protein production, molecular biology, and assay services — overlapping with OneWorld but also providing clinical and commercial-scale manufacturing that dwarfs a single-site specialist.
- Charles River Laboratories: Charles River is a large CRO/CDMO offering protein production, cell line development, and assay services alongside broader preclinical and clinical offerings — overlapping with OneWorld's preclinical protein and assay services but at much greater scale.
- BioLegend (now part of Revvity/Sigma): BioLegend specializes in antibody and immunoassay development and custom reagent manufacturing — directly comparable to OneWorld's assay development and custom reagent capabilities, including ELISAs and multiplex bead-based assays.
Direct peers
- Sino Biological: Sino Biological offers custom protein expression and purification services across mammalian, insect, and microbial systems, plus custom assay development — a direct overlap with OneWorld's ProteoWay™ protein production and assay development services.
- LakePharma (now part of Curia): LakePharma was a US-based CRO specializing in antibody and protein engineering, molecular cloning, and assay development — closely comparable to OneWorld's focus on recombinant protein production and custom assay design, particularly for biotech clients.
- GenScript: GenScript is a global CRO/CDMO specializing in gene synthesis, molecular cloning, protein production, and assay development — directly competing with OneWorld Biotech's NucleoWay™ and ProteoWay™ offerings across multiple expression systems.
Emerging players
- Cambridge ProteinWorks (CPI): Cambridge ProteinWorks is a UK-based emerging CRO focused on recombinant protein expression and characterization — direct overlap with OneWorld's ProteoWay™ platform serving biotech R&D clients, with a more focused scale-up orientation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
One World Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
One World Biotech leadership team
Management profileNumber of profiles
One World Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
One World Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about One World Biotech
What does One World Biotech do?
OneWorld Biotech is a Contract Research Organization (CRO) that delivers fully custom, project-based protein expression and purification, molecular cloning and RNA synthesis, and assay development services to biotech and pharmaceutical clients. The company specializes in difficult-to-express proteins, complex custom assay design, and cost-effective cloning projects using proprietary ProteoWay™ and NucleoWay™ platforms across microbial, insect, mammalian, and cell-free expression systems. All work is executed in-house at its 3,500 sq ft HEPA-filtered laboratory in Warminster, Pennsylvania.
Is One World Biotech a public or private company?
One World Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was One World Biotech founded?
One World Biotech was founded in 2007. It employs 11 to 50 people.
Where is One World Biotech based?
One World Biotech is headquartered in Warminster, United States, in the North America region.
How does One World Biotech make money?
One revenue line is on record: custom CRO Services.
Who are One World Biotech's main competitors?
Broad incumbents on record are Eurofins Scientific, Bio-Techne, Thermo Fisher Scientific, WuXi AppTec, Charles River Laboratories and BioLegend (now part of Revvity/Sigma). Direct peers are Sino Biological, LakePharma (now part of Curia) and GenScript. Cambridge ProteinWorks (CPI) is listed as an emerging player.
Does One World Biotech have an API?
No public API is recorded for One World Biotech.
What industry is One World Biotech in?
One World Biotech's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 541714 and its SIC code is 8731.